Aligos Therapeuticsinc Stock Story
| ALGS Stock | USD 0.79 0.05 5.95% |
Slightly above 62% of Aligos TherapeuticsInc's investor base is looking to short. The analysis of the overall investor sentiment regarding Aligos TherapeuticsInc suggests that many traders are alarmed. Aligos TherapeuticsInc's investor sentiment overview provides quick insight into current market opportunities from investing in Aligos TherapeuticsInc. The current market sentiment, together with Aligos TherapeuticsInc's historical and current headlines, can help investors time the market. In addition, many technical investors use Aligos TherapeuticsInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aligos TherapeuticsInc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Aligos daily returns and investor perception about the current price of Aligos TherapeuticsInc as well as its diversification or hedging effects on your existing portfolios.
Aligos |
Requested story not found. it has been either deleted or moved. View all stories for Aligos TherapeuticsInc.
Aligos TherapeuticsInc Latest Timeline
Aligos TherapeuticsInc is listed for 0.79. About 21.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aligos TherapeuticsInc recorded a loss per share of 1.36. The entity had not issued any dividends in recent years.Check out Aligos TherapeuticsInc Hype Analysis, Aligos TherapeuticsInc Correlation and Aligos TherapeuticsInc Performance. For more information on how to buy Aligos Stock please use our How to Invest in Aligos TherapeuticsInc guide.Note that the Aligos TherapeuticsInc information on this page should be used as a complementary analysis to other Aligos TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Aligos Stock analysis
When running Aligos TherapeuticsInc's price analysis, check to measure Aligos TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aligos TherapeuticsInc is operating at the current time. Most of Aligos TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Aligos TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aligos TherapeuticsInc's price. Additionally, you may evaluate how the addition of Aligos TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Aligos TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aligos TherapeuticsInc. If investors know Aligos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aligos TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.242 | Quarterly Revenue Growth (0.24) | Return On Assets (0.37) | Return On Equity (0.89) |
The market value of Aligos TherapeuticsInc is measured differently than its book value, which is the value of Aligos that is recorded on the company's balance sheet. Investors also form their own opinion of Aligos TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Aligos TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aligos TherapeuticsInc's market value can be influenced by many factors that don't directly affect Aligos TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aligos TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aligos TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aligos TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.